Latest Content

A wearable cough monitor generated clinically useful cough data, but patients only wore the device about half of the days of the study period.

The approval of remibrutinib for patients with chronic spontaneous urticaria was supported by data from the phase 3 REMIX-1 and REMIX-2 clinical trials.

Immune gene signatures were linked to illness severity and treatment response in sepsis and other critical conditions.

Patients with immunoglobulin M-type monoclonal gammopathy did not experience a survival benefit from targeted therapies, a study found.

Paternal prepubertal passive smoke exposure is linked to impaired lung function trajectories in offspring, persisting into adulthood.

Second primary malignancies in patients with small cell lung cancer are often misdiagnosed as distant metastases.

Electronic health record (EHR)–based “e-phenotypes” combining lab data, coding, and AI could dramatically improve early detection and management of chronic kidney disease.

Experian Health’s 2025 State of Claims survey shows rising denial rates, data errors, and low artificial intelligence adoption despite providers’ belief in its potential.

Hope Krebill of the Masonic Cancer Alliance at the University of Kansas Medical Center outlines patient navigation models that improve outcomes and reduce missed appointments.